Virtual Sickle Cell Regional Conference
The event, entitled “Sickle Cell Disease, Practical Issues XVIII: What’s in Your Genes? The Promise of a Cure,” is devoted to educating healthcare professionals on sickle cell disease.
When:May 15, 20218:00 AM - 4:30 PM
To offer up-to-date information on the treatment and management of sickle cell disease, the University of South Alabama Comprehensive Sickle Cell Center will host the 2021 Sickle Cell Regional Conference on May 15, 2021, from 8 a.m. until 4:30 p.m.
This one-day virtual conference features three internationally recognized experts in sickle cell disease, including John F. Tisdale, M.D., senior investigator and director of the molecular and clinical hematology branch of the National Institutes of Health; Frederick Goldman, M.D., professor and director of the Lowder Blood and Marrow Transplant Program at the University of Alabama at Birmingham; and Tim Townes, Ph.D., Professor Emeritus of Biochemistry and Molecular Genetics at UAB.
The event, entitled “Sickle Cell Disease, Practical Issues XVIII: What’s in Your Genes? The Promise of a Cure,” is devoted to educating healthcare professionals on sickle cell disease. The conference is targeted to physicians, pharmacists, advanced practice providers, nurses, hospitalists, students and allied health professionals.
Register online at www.usa-cme.com.
This event will be of particular interest to OB-GYN physicians, family medicine physicians, advanced practice nurses, physician assistants, nurse midwives, ultrasonographers, and other healthcare professionals associated with obstetrics and gynecology.
A Night Honoring Healers, presented by The Mapp Family Foundation, will be an inspirational evening honoring the remarkable stories of our USA Health care team members in action as they provide exceptional, compassionate care to our patients.
The USA Health Mitchell Cancer Institute’s Think Pink Tea is a free celebration of breast cancer awareness — a commitment to patients, survivors, advocates, and the friends and family of those impacted by breast cancer.